SUMMARY: Enterotoxigenic Escherichia coli (ETEC) has the potential to cause nosocomial infantile diarrhea in a hospital setting. We detected 12 ETEC serotype O128:H45 isolates from diarrheal neonates in our neonatal unit from July through October 2012. These infants developed hospital-acquired and epidemiologically related diarrhea. Pulsed-field gel electrophoresis analysis and multilocus sequence typing of these 12 isolates suggested that a specific clone of ETEC serotype O128:H45-CS21-ST2332 caused nosocomial diarrhea among neonates. Of concern, this ETEC clone strain was resistant to multiple drugs, particularly third-generation cephalosporins.
INTRODUCTION
Enterotoxigenic Escherichia coli (ETEC) is an important cause of diarrhea in infants and young children in developing countries (1) . Approximately 280-400 million ETEC-associated diarrhea cases occur annually in children younger than 5 years old (2) . A median of 13z (range 3-39z) of diarrheal specimens were positive for ETEC in 51 studies conducted in children (3) . Birth cohort studies of infants in developing countries suggest that children aged > 6 months may be at increased risk owing to not being exclusively breastfed and the introduction of supplemental foods resulting in increased consumption of contaminated water or foods (4) (5) (6) . ETEC is also an important causative agent responsible for nosocomial infantile diarrhea in hospital settings (7) (8) (9) . Occasional nosocomial outbreaks caused by ETEC among neonates have been documented (10) (11) (12) . The role of ETEC as a cause of infectious diarrhea is under-recognized in our country because ETEC diagnostic methods are unavailable in the clinical laboratories. Since July 2012, the diagnostic testing of diarrheagenic E. coli (DEC) was included in the routine surveillance program of infectious diarrhea by the public health laboratory of Shanghai Municipal Center for Disease Control and Prevention (CDC). Children's Hospital of Fudan University was selected as one of the 4 surveillance sentinel sites for infectious diarrhea. We noted a clonal spread of ETEC O128:H45 among neonates with nosocomial diarrhea. This study retrospectively described the phenotypic and genotypic profiles of ETEC O128:H45 isolates causing nosocomial neonatal diarrhea.
MATERIALS AND METHODS
The stool samples collected from the diarrheal infants in the neonate units were routinely screened for enteric pathogens. Shigella spp., Salmonella spp., Yersinia enterocolitica, Campylobacter jejuni and C. coli, Aeromonas spp., Vibrio spp., and rotaviruses were screened as previously described (13, 14) . For identifying DEC, stool swab specimens were incubated overnight on an SSI enteric medium plate (State Serum Institute; Copenhagen, Denmark). Five medium-sized colonies (lactosefermenting or non-fermenting) were selected and pooled for DNA extraction and multiplex PCR assay using the SSI-DEC-PCR kit (State Serum Institute) at the CDC laboratory. Agarose gel electrophoresis was performed to confirm the target bands of virulence genes. Subsequently, individual colonies from positive ETEC samples were analyzed using separate PCR assays to screen the exact colony containing eltA encoding heat labile toxin, stIa and stIb encoding porcine heat-stable toxin (STp) and human heat-stable toxin (STh), respectively, as previously described (15) . ETEC colonies enriched for toxic genes were used for the biochemical tests and preserved at -809 C in Brain Heart Infusion medium (Difco; Detroit, MI, USA) containing 30z glycerol to further characterize the serotypes, colonization factors, and genotypes. The isolates were O:H-serotyped using commercial antisera kits (State Serum Institute). The isolates were subtyped by pulsed-field gel electrophoresis (PFGE) using the restriction enzyme XbaI and genotyped by multilocus sequence typing (MLST) using standard protocols (16, 17) . Detection of 19 different colonization factors (CFs) was performed by multiplex PCR as previously described (15) . In addition, 6 putative virulence factors for ETEC (clyA, eatA, leoA, tibC, tia, and east-1) were analyzed as previously described (18) . 
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Antimicrobial susceptibility testing of ETEC was performed using the minimum inhibitory concentrations (MICs). Antimicrobial classes and MIC resistance breakpoints were defined using the criteria established by the Clinical and Laboratory Standards Institute (19) . The clinical data were obtained from the hospital medical records and reviewed by a principal investigator.
RESULTS
Thirteen neonates had ETEC exclusively isolated in the stool samples during the period of July 14 to October 14, 2012. One ETEC isolate was detected in July, 4 isolates in August, 7 isolates in September, and 1 isolate in October. In 1 case, rotavirus was co-detected. Afterward, no ETEC was isolated in the submitted stool samples from the neonate unit. Of 13 neonates with ETEC infection, 11 cases were considered to have developed hospital-acquired diarrhea because diarrhea occurred 3 days after hospital admission or within 3 days of discharge; 1 case developed diarrhea 1 day after exposure to her sister who developed diarrhea on the day when she was discharged from the neonate unit; 1 case developed diarrhea at home and then was admitted to the hospital for fever and loose stool. The 13 ETEC-infected infants (6 girls and 7 boys) were aged between 6 and 63 days on admission. Eleven infants with hospitalacquired diarrhea and 1 secondary case were formulafed; 1 infant was breast-fed with formula supplementation before developing diarrhea at home. Thirteen diarrheal infants passed frequent watery stools or loose stools (5-12 times/24 h), 4 had mucus in the stools and 1 had visible blood in the stool. Four infants experienced vomiting, 7 had mild fever (38-399 C) for 1-4 days, and 3 had moderate dehydration. Thirteen neonates received parenteral antibiotics such as third-generation cephalosporins or ampicillin-sulbactam. All ETEC-infected infants fully recovered 3-5 days after the onset of diarrhea.
Detailed serotyping of ETEC isolates showed that 11 infants with hospital-acquired diarrhea and 1 infant exposed to her sibling with hospital-acquired diarrhea excreted ETEC O128:H45. However, the ETEC isolate recovered from the infant with home-acquired diarrhea was non-O128:H45 serotype. Twelve ETEC O128:H45 isolates that were positive for STh-gene, also had identical or almost identical PFGE patterns (Fig. 1) and the same sequence type (ST2332), which were distinctly different from 1 ETEC non-O128:H45 strain that was positive for STp-gene and had sequence type ST182. All 12 ETEC O128:H45 isolates expressed CS21, clyA, and eatA, and 10 isolates also expressed CFA/I. However, 1 ETEC non-O128:H45-ST182 isolate expressed CS6, clyA, eatA, leoA, tia, and east-1. All 13 ETEC isolates were lactose-fermenting. All 13 ETEC isolates were susceptible to gentamicin, kanamycin, amikacin, chloramphenicol, ofloxacin, ciprofloxacin, and levofloxacin; resistant to nalidixic acid, tetracycline, ampicillin, streptomycin, sulfisoxazol, trimethoprim-sulfamethoxazol; and had intermediate-resistance to amoxicillin-clavulanic acid. However, 12 ETEC O128:H45 isolates were also resistant to cefotaxime, cefepime, and ceftazidime.
Detailed information of these 13 infants and 13 ETEC isolates is summarized in Table 1 .
DISCUSSION
Neonatal nosocomial diarrhea is a big concern in our setting because of the shortage of healthcare providers and the admission overload in neonate units. The findings of this study indicate that ETEC is a neglected pathogen causing nosocomial diarrhea among neonates. Currently, as the ETEC diagnostic methods are not widely available in clinical laboratories, ETEC-associated nosocomial infection cannot be recognized in a timely manner, and consequently, a cluster outbreak could occur. ETEC is primarily spread through contaminated food or water, and is often linked to outbreaks of gastrointestinal illness (20, 21) . Although 12 cases of ETEC O128:H45 infection seemed to be temporally unrelated, 12 ETEC O128:H45 isolates were verified to be genetically related based on their indistinguishable PFGE pattern and MLST genotype, which is distinctly different from the 1 ETEC non-O128:H45 isolate recovered from an infant with home-acquired diarrhea. Thus, we reason that an epidemiologically related ETEC clone, that is, ETEC O128:H45-CS21-ST2332 strain, was responsible for nosocomial diarrhea in the neonate unit. Several hospital-acquired outbreaks of diarrhea in infants and children caused by ETEC have been described (7) (8) (9) (10) (11) (12) MLST, multilocus sequence typing; STh, human heat-stable toxin; STp, porcine heat-stable toxin; TET, tetracycline; AMC, amoxicillin-clavulanic acid; AMP, ampicillin; SXT, trimethoprim-sulfamethoxazole; NAL, nalidixic acid; FEP, cefepime; CTX, cefotaxime; TMP, trimethoprim; CAZ, ceftazidime; S3, sulfisoxazol; STR, streptomycin. * represents medium resistance.
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ETEC-Associated Diarrhea among Neonates transmission for this cluster outbreak of nosocomial ETEC infection in the neonate unit. Given that all 12 ETEC O128:H45-infected infants were formula-fed, and that ETEC O128:H45 was not isolated from infants with home-acquired diarrhea who were admitted to the neonate unit during the same period, we speculated that ETEC O128:H45-CS21-ST2332 strain was most likely introduced through contaminated bottled milk. The previous studies show that consumption of formula feeds results in a 4-fold increase in the risk of asymptomatic ETEC infection, and the incidence of diarrhea in these infants is 3-times higher than it is in strictly breastfed infants (22, 23) . It was unlikely that asymptomatic ETEC infection would be identified in the neonate units during the same periods because non-diarrheal stool samples were not routinely screened for enteric pathogens. When an ETEC-associated outbreak of diarrheal disease is noted in a neonate unit, it is necessary to investigate the incidence of asymptomatic infection and the transmission source in order to implement effective preventive measures. Interestingly, an ETEC O128:H45-ST2332 clone was also reported to be responsible for an outbreak of nosocomial diarrhea during May and June in 2012 among neonates from 4 hospitals in Zigong City, Sichuang Province, which is located in the southwest of China and far away from Shanghai (24) . The cluster outbreak caused by ETEC O128:H45-ST2332 clone was detected in the middle of July 2012 in Shanghai. Nevertheless, ETEC serotype O128:H45-CS21-ST2332 has not been reported to be related to be an ETEC outbreak outside of China. The emergence of ETEC serotype O128:H45 strain and its clinical role in infantile diarrhea deserve our continuous attention and monitoring. All these 12 ETEC O128:H45 isolates possessed STh and CS21, and most of isolates also possessed CFA/I. Enterotoxins and plasmid-encoded CFs are two important virulence factors for pathogenic ETEC. Epidemiological studies suggest a significant correlation of ETEC expressing ST and diarrhea (25) . In addition, large epidemiological studies indicate that STh-producing ETEC may be more pathogenic than STp-producing ETEC, and most CFs were associated with a single toxin profile (6) . Information about ETEC phenotypes has implications for designing vaccine components. Although ETEC O128:H45 isolates displayed a multidrug resistance pattern, diarrheal infants had a full recovery even with treatment with antibiotics, to which ETEC was resistant in vitro. This benign outcome suggests that antibiotic therapy is unnecessary for non-invasive ETEC-associated gastrointestinal infection in infants, or that there is a discrepancy between in vitro resistance and in vivo clinical outcomes. However, ETEC resistance to clinically important antibiotics such as third-generation cephalosporins and amoxicillin-clavulanate imposes a challenge on empirical antimicrobial treatment during an outbreak situation and severe infection. Elimination of ETEC from symptomatic neonates may be essential in the event of an outbreak to minimize the risk of crossinfection.
This ETEC-related nosocomial outbreak in the neonate unit emphasizes the necessity for clinical laboratories to include ETEC in routine diagnostic capabilities. Utilization of standardized molecular methods such as 130 130 PFGE and MLST in the public health laboratories enhances our capacity to recognize small, dispersed clusters of potentially related infections. Continuous monitoring of ETEC O128:H45 infection in infants and understanding of the route of transmission are needed.
